The FDA approved KALYDECO (ivacaftor) a University of Washington-tested drug to treat the genetic mechanism of cystic fibrosis
On Jan. 31, 2012, the FDA approved a KALYDECO (ivacaftor), University of Washington-tested drug to treat the genetic…
Alan Aderem, PhD, became president of Seattle BioMed – only the second in its more than 35-year history
On Jan. 1, 2012 Alan Aderem, Ph.D., became president of Seattle BioMed, now known as Center for Infectious…
Amnis Corp. was acquired by EMD Millipore
On Aug. 30, 2011, Amnis, a Seattle-based manufacturer of advanced cell imaging systems, announced the company had been…
The FDA approved Seattle Genetics’ Adcetris (brentuximab vedotin)
On Aug. 19, 2011, the U.S. Food and Drug Administration (FDA) approved Seattle Genetics’ Adcetris (brentuximab vedotin), making…
Gilead Sciences acquired Calistoga Pharmaceuticals for $375 Million
On Feb. 22, 2011, Foster City, Calif-based Gilead Sciences and Calistoga Pharmaceuticals announced Gilead’s acquisition of Calistoga for…
Pacific Northwest Diabetes Research Institute began clinical trials on antioxidant drug treatments on volunteers from Madigan Army Medical
In 2011, the Pacific Northwest Diabetes Research Institute began clinical trials on antioxidant drug treatments on volunteers from…
Cardiac Science acquired by Opto Circuits of India for $55 million
On Dec. 3, 2010, Banglore, India-based Opto Circuits announced completion of its merger with Bothell-based Cardiac Science Corp….
Trubion Pharmaceutical was acquired by Emergent BioSolutions
On Oct. 28, 2010, Emergent BioSolutions announced it had completed the acquisition of Seatte-based Trubion Pharmaceutical for upfront…
HaloSource completed its IPO
On Oct. 12, 2010, HaloSource completed its IPO on the London Stock Exchange and raised $50 million in…
ZymoGenetics was acquired by Bristol-Myers Squibb for $885 million
On Oct. 12, 2010, Bristol-Myers Squibb Company announced it had completed its acquisition of ZymoGenetics. Bristol-Myers Squibb initiated…
Pacific Northwest Diabetes Research Institute appointed Jack Faris as CEO
On Sept. 15, 2010, Pacific Northwest Diabetes Research Institute appointed Jack Faris, Ph.D., as Chief Executive Officer. Previously,…
OriGene Technologies aquired Blue Heron Biotechnology
On Aug. 12, 2010, OriGene Technologies based in Rockville, Maryland, announced the acquisition of Blue Heron Biotechnology, a…
Marina Biotech acquired Cequent Pharmaceuticals for $44 million
On Jul. 22, 2010, MDRNA announced that MDRNA shareholders approved the issuance of shares of MDRNA common stock…
SonoSite acquired VisualSonics for $67.9 million
On Jun. 30, 2010, SonoSite acquired VisualSonics, a Toronto-based company focused on ultra high-frequency micro-ultrasound technology, for $67.9…
William Hagopian was appointed Scientific Director at the Pacific Northwest Diabetes Research Institute
On Nov. 11, 2009, the Pacific Northwest Diabetes Research Institute announced the appointment of William Hagopian, M.D., Ph.D.,…
Omeros Corp completed its IPO
On Oct. 8, 2009, Omeros Corp. launched an initial public offering at $10.00 per share and raised $62.1…
OHSU, University of Washington scientists partner to form regional center aimed at combating infectious diseases
On Apr. 15, 2009, Oregon Health & Science University (OHSU) and the University of Washington (UW), along with…
The Washington State Academy of Sciences was founded
On Nov. 21, 2008, the Washington State Academy of Sciences (WSAS) was launched. Authorized by the state legislature…
Merck announced it was closing its Rosetta Research Center
On Oct. 22, 2008, Merck announced it was closing its Rosetta Research Center and would layoff 300 employees…
Sonus Pharmaceuticals was acquired by OncoGenex
On Aug. 20, 2008, Sonus Pharmaceuticals was acquired by OncoGenex Technologies in a reverse merger transaction worth $10.36…
Washington BioEvolution, 2008
Washington BioEvolution illustrates life science companies and non-profit research organization in the State of Washington by the year…
National Cancer Institute reported changes in adult stem cells may underlie disease associated with accelerated aging
On Mar. 2, 2008, adult stem cells may provide an explanation for the cause of a Hutchinson-Gilford Progeris…
Pacific Northwest Research Institute changed name to Pacific Northwest Diabetes Research Institute
On Feb 25, 2008, the Pacific Northwest Research Institute changed its name to Pacific Northwest Diabetes Research Institute…
Biotechnology | Disease | FDA | Therapeutics
ZymoGenetics received FDA authorization to manufacture the product Thrombin topical (Recombinant)
On Jan. 17, 2008, ZymoGenetics received U.S. Food and Drug Administration (FDA) authorization to manufacture the product Thrombin…
The One Health approach was recommended for pandemic preparedness
On Dec. 4, 2007, representatives of 111 countries and 29 international organizations met in New Delhi India for…
Safeway was awarded the E. Donnall Thomas Medal of Achievement Medal
On Oct. 9, 2007, the Fred Hutchinson Business Alliance announced that the 2007 E. Donnall Thomas Medal of…
BioLife Solutions was incorporated in Seattle
On Aug. 24, 2007, BioLife Solutions was incorporated in Seattle. BioLife Solutions (formerly Cryomedical Sciences) is a class-defining…
University of Washington physicians performed adult heart-lung transplant
On Aug. 16. 2007, surgeons at the University of Washington (UW) Medical Center performed Seattle’s first adult heart-lung…
Researchers from the Hutchinson Center and Seattle Children’s developed a “tumor paint” that illuminates cancerous cells
On Jul. 15, 2007, Dr. Jim Olson and colleagues from Fred Hutchinson Cancer Research Center and Seattle Children’s…
Eli Lilly completed its acquisition of ICOS Corp for $23 billion
On Jan. 29, 2007, Eli Lilly announced it had completed its acqusition of ICOS Corp. for $2.3 billion…